Brain abscess caused by Streptomyces infection following penetration trauma: Case report and results of susceptibility analysis of 92 isolates of Streptomyces species submitted to the CDC from 2000 to 2004

Charles E. Rose, June M. Brown, John F. Fisher

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The case of a patient who presented with a brain abscess caused by Streptomyces infection following penetrating cerebral trauma with a soil-contaminated object generated an interest in optimizing antimicrobial therapy. Collaboration with the Centers for Disease Control and Prevention led to the analysis of susceptibility data for Streptomyces isolates that suggested that amikacin (100% susceptibility for 92 isolates tested) and linezolid, an oxazolidinone (100% susceptibility for 41 isolates tested), offer reliable activity against all isolates.

Original languageEnglish (US)
Pages (from-to)821-823
Number of pages3
JournalJournal of clinical microbiology
Volume46
Issue number2
DOIs
StatePublished - Feb 1 2008

Fingerprint

Brain Abscess
Linezolid
Streptomyces
Centers for Disease Control and Prevention (U.S.)
Oxazolidinones
Amikacin
Wounds and Injuries
Infection
Soil
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

@article{d5d0dce85f5d4fe48299506b852be617,
title = "Brain abscess caused by Streptomyces infection following penetration trauma: Case report and results of susceptibility analysis of 92 isolates of Streptomyces species submitted to the CDC from 2000 to 2004",
abstract = "The case of a patient who presented with a brain abscess caused by Streptomyces infection following penetrating cerebral trauma with a soil-contaminated object generated an interest in optimizing antimicrobial therapy. Collaboration with the Centers for Disease Control and Prevention led to the analysis of susceptibility data for Streptomyces isolates that suggested that amikacin (100{\%} susceptibility for 92 isolates tested) and linezolid, an oxazolidinone (100{\%} susceptibility for 41 isolates tested), offer reliable activity against all isolates.",
author = "Rose, {Charles E.} and Brown, {June M.} and Fisher, {John F.}",
year = "2008",
month = "2",
day = "1",
doi = "10.1128/JCM.01132-07",
language = "English (US)",
volume = "46",
pages = "821--823",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Brain abscess caused by Streptomyces infection following penetration trauma

T2 - Case report and results of susceptibility analysis of 92 isolates of Streptomyces species submitted to the CDC from 2000 to 2004

AU - Rose, Charles E.

AU - Brown, June M.

AU - Fisher, John F.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - The case of a patient who presented with a brain abscess caused by Streptomyces infection following penetrating cerebral trauma with a soil-contaminated object generated an interest in optimizing antimicrobial therapy. Collaboration with the Centers for Disease Control and Prevention led to the analysis of susceptibility data for Streptomyces isolates that suggested that amikacin (100% susceptibility for 92 isolates tested) and linezolid, an oxazolidinone (100% susceptibility for 41 isolates tested), offer reliable activity against all isolates.

AB - The case of a patient who presented with a brain abscess caused by Streptomyces infection following penetrating cerebral trauma with a soil-contaminated object generated an interest in optimizing antimicrobial therapy. Collaboration with the Centers for Disease Control and Prevention led to the analysis of susceptibility data for Streptomyces isolates that suggested that amikacin (100% susceptibility for 92 isolates tested) and linezolid, an oxazolidinone (100% susceptibility for 41 isolates tested), offer reliable activity against all isolates.

UR - http://www.scopus.com/inward/record.url?scp=38949148642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949148642&partnerID=8YFLogxK

U2 - 10.1128/JCM.01132-07

DO - 10.1128/JCM.01132-07

M3 - Article

C2 - 18094128

AN - SCOPUS:38949148642

VL - 46

SP - 821

EP - 823

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 2

ER -